Dinauer Lab

Mary C. Dinauer, MD, PhD

Mary Dinauer, MD, PhD, studies the superoxide-generating leukocyte NADPH oxidase and the role of oxidant production by neutrophils and macrophages in microbial killing, the inflammatory response, and autoimmunity. Inactivating mutations in the NADPH oxidase result in chronic granulomatous disease (CGD), a primary immunodeficiency associated with recurrent bacterial and fungal infections as well as a variety of chronic inflammatory disorders, including inflammatory bowel disease and discoid lupus. Moreover, hypomorphic NADPH oxidase gene variants are now linked to inflammatory bowel disease and autoimmunity. These clinical manifestations reflect the dual importance of the NADPH oxidase both for microbial killing and for negatively regulating cellular processes that limit inflammation by redox mechanisms.

Principal investigator

Mary  C.  Dinauer, MD, PhD

Mary C. Dinauer, MD, PhD

Emeritus Faculty

Recent publications

RSS Error: A feed could not be found at `https://profiles.wustl.edu/en/persons/mary-dinauer/publications/?format=rss`; the status code is `404` and content-type is `text/html;charset=utf-8`

Contact Us

Principal Investigator

Mary C. Dinauer, MD, PhD
Voice: 314-286-0542
Fax: 314-286-2893

Administrative Coordinator
Tina McGrath
Voice: 314-286-0712
Email: mcgratht@wustl.edu

U.S. mail

Dinauer Lab
Department of Pediatrics | Hematology & Oncology
660 S. Euclid Ave.
Campus Box 8208
St. Louis, MO 63110